AtonRa Partners lowered its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 17.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,370 shares of the company’s stock after selling 1,804 shares during the period. AtonRa Partners’ holdings in Intellia Therapeutics were worth […]